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To determine the clinicopathologic characteristics and prognosis of gastric cancer in young 
patients, a total of 1985 gastric cancer patients who had undergone gastrectomy at our hospi-
tal were reviewed. The male-to-female ratio was significantly lower in the young patients than 
in either the middle-aged (P < 0.0001) or elderly patients (P < 0.0001). Undifferentiated carci-
noma was observed more frequently in the young patients compared with either the middle-
aged (P < 0.0001) or elderly patients (P < 0.0001). Furthermore, peritoneal metastasis was 
observed more frequently in the young patients than in either the middle-aged (P < 0.005) or 
elderly patients (P < 0.005). Five-year survival rates were 61.0, 73.6 and 68.1% in the young, 
middle-aged and elderly patients, respectively. The prognosis of the middle-aged patients was 
significantly better than that of either the young or the elderly patients (P < 0.05). Multivari-
ate analysis indicated that age was an independent prognostic factor. Peritoneal recurrence 
was more frequently observed in the young patients than either the middle-aged or the elderly 
patients (P < 0.05). Gastric cancer in young patients has unique characteristics, namely, a 
predominance of female patients and a high frequency of undifferentiated cancer and perito-
neal metastasis and recurrence. 
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Gastric cancer is frequent in middle-aged and 
elderly populations. Although gastric cancer is 
rare in young populations (Okamoto et al., 1988; 
Mitsudomi et al., 1989), it has been reported that 
gastric cancer in young patients has some unique 
characteristics compared with that in middle-
aged and elderly patients. For instance, the male-
to-female ratio shows a predominance of females 
among younger patients (Bloss et al., 1980; Mori 
et al., 1985; Sandler and Holland, 1987; Tso et al., 
1987). Furthermore, a significantly higher fre-
quency of both Borrmann type 4 and poorly dif-
ferentiated adenocarcinoma with a scirrhus growth 
pattern has been noted as a characteristic of gastric 
cancer in young patients (Bloss et al., 1980; Sandler 
and Holland, 1987; Tso et al., 1987; Okamoto et al., 
1988; Mitsudomi et al., 1989). On the other hand, 
the prognosis of gastric cancer in young patients re-
mains unclear thus far. The aim of the present study 
was to clarify the clinicopathologic characteristics 
and prognosis of gastric cancer in young patients.
Materials and Methods
Patients
The present study was based on a retrospective anal-
ysis of 1985 patients with gastric adenocarcinoma 
who underwent gastrectomy at our institution be-
tween January 1975 and December 2000. The clini-
copathologic findings were determined according 
to the Japanese Classification of Gastric Carcinoma 
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(Japanese Gastric Carcinoma Association, 1998). Pa-
tients were periodically checked for early recurrence 
by diagnostic imaging (chest X-ray, double-contrast 
barium meal study, upper gastrointestinal fiberscopy, 
ultrasonography and computed tomography). All pa-
tients were monitored for at least 5 years. The causes 
of death and pattern of recurrence were determined 
by reviewing the medical records, including labora-
tory data, ultrasonography, computed tomography, 
scintigraphy, peritoneal puncture and laparotomy, or 
by direct inquiries addressed to bereaved families. 
In some cases, postmortems were performed to es-
tablish the cause of death.
 
Statistical analysis 
 
Association among factors was evaluated by the 
chi-squared test, and the significance of differences 
Table 1.  Correlation between age and clinicopathologic features 
 Variables  Age classification 
     Young [84] Middle-aged [1314] Elderly [587]
Gender  Male 32 (38.1)***, †††  871 (66.3) 363 (61.8) 
 Female 52 (61.9)  443 (33.7) 224 (38.2)
Histology§  Differentiated 10 (11.9)***, †††  589 (44.8) 330 (56.2)‡‡‡
 Undifferentiated 74 (88.1)  725 (55.2) 257 (43.8)
Tumor size < 8 cm 53 (63.1)*  962 (73.2) 430 (73.3)
 ≥ 8 cm 31 (36.9)  352 (26.8) 157 (26.7)
Serosal invasion Absent 49 (58.3)  825 (62.8) 377 (64.2) 
 Present 35 (41.7)  489 (37.2) 210 (35.8)
Lymph node metastasis Absent 46 (54.8)  760 (57.8) 336 (57.2) 
 Present 38 (45.2)  554 (42.2) 251 (42.8)
Lymphatic involvement Absent 39 (46.4)  701 (53.3) 295 (50.3)
 Present 45 (53.6)  613 (46.7) 292 (49.7) 
Vascular involvement Absent 61 (72.6)†  873 (66.4) 345 (58.8)‡‡
 Present 23 (27.4)  441 (33.6) 242 (41.2)
Peritoneal metastasis Absent 73 (86.9)†† 1222 (93.0) 558 (95.1)‡‡
 Present 11 (13.1)   92 (7.0)  29 (4.9)
Liver metastasis Absent 84  (100) 1274 (97.0) 562 (95.7)
 Present  0 (0)     40 (3.0)  25 (4.3)
Stage I/II 52 (61.9)  852 (64.8) 377 (64.2)
 III/IV 32 (38.1)  462 (35.2) 210 (35.8)
Lymph node dissection|| D0/D1  8 (9.5)††  206 (15.7)  156 (26.6)‡‡‡
 D2/D3 76 (90.5) 1108 (84.3) 431 (73.4)
Multiple gastric cancer Absent 82 (97.6) 1233 (93.8) 539 (91.8)
 Present  2 (2.4)   81 (6.2)  48 (8.2)
Curability Curative 74 (88.1) 1137 (86.5) 520 (88.6)
 Non-curative 10 (11.9)  177 (13.5)  67 (11.4)
 [  ], number of patients; (  ), %. 
 § Differentiated, papillary or tubular adenocarcinoma; undifferentiated, poorly differentiated or undifferentiated ad-
enocarcinoma, or signet ring cell carcinoma.
 || D0, no dissection; D1, dissection of group-1 lymph nodes; D2, dissection of group-1 and -2 lymph nodes; D3, dis-
section of group-1 to -3 lymph nodes.
 * P < 0.05: young versus middle-aged. 
 † P < 0.05: young versus elderly. 
 ‡‡ P < 0.005: middle-aged versus elderly. 
 †† P < 0.005: young versus elderly. 
 *** P < 0.0001: young versus middle-aged. 
 ††† P < 0.0001: young versus elderly. 
 ‡‡‡ P < 0.0001: middle-aged versus elderly. 
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among the means was determined by the Mann-
Whitney U test. Survival curves were calculated ac-
cording to the Kaplan-Meier method. Survival data 
shown in the present study were cancer specific. To 
this end, patients who died from another malignan-
cy, another disease or an accident were treated as 
censored cases in the survival analysis. Differences 
between survival curves were examined with the 
log rank test. Multivariate analysis was performed 
using the Cox proportional hazards model and a 
stepwise procedure. The covariates included gender, 
age, histological classification, tumor size, depth of 
invasion, lymph node metastasis, lymphatic vessel 
invasion, blood vessel invasion, peritoneal metasta-
sis, liver metastasis and lymph node dissection. The 
accepted level of significance was P < 0.05. Stat 
View software (Abacus Concepts, Berkeley, CA) 
was used for all statistical analyses.
 
 
Results
 
Clinicopathologic characteristics of young 
patients 
 
Patient age ranged from 20 to 93 years with a mean 
of 62 years, and 1266 patients were male and 719, 
female. According to previous reports (Maeta et 
al., 1995; Saito et al., 2006), patients were divided 
into 3 groups as follows: young patients aged under 
40 years; middle-aged patients aged 40 years and 
over and under 70 years; and elderly patients aged 
70 years and over. The correlation between age and 
clinicopathologic factors is shown in Table 1. The 
male-to-female ratio was significantly lower in the 
young patients than in either the middle-aged (P < 
0.0001) or elderly patients (P < 0.0001). Undiffer-
entiated carcinoma was observed more frequently 
in the young patients than in either the middle-aged 
(P < 0.0001) or elderly patients (P < 0.0001). Tumor 
size in the young patients was significantly larger 
than that in the middle-aged patients (P < 0.05). The 
frequency of blood vessel invasion was significantly 
lower in the young patients than that in the elderly 
patients (P < 0.05). Furthermore, peritoneal metas-
tasis was observed more frequently in the young 
than in either the middle-aged (P < 0.005) or elderly 
patients (P < 0.005).
 
Age and survival
 
Among 1985 patients, 1731 underwent curative sur-
gery and were included in the survival analysis. At 
the time of analysis, the median follow-up of 1069 
surviving patients was 108 months. Of 662 deaths, 
334 were related to recurrence of gastric cancer, 
328 were due to either an unrelated malignancy, 
an unrelated disease or an accident. Five-year sur-
vival rates were 61.0, 73.6 and 68.1% in the young, 
middle-aged and elderly patients, respectively. The 
prognosis of the middle-aged patients was signifi-
cantly better than that of either the young or the 
elderly patients (P < 0.05; Fig. 1). We employed 
Cox’s proportional hazards model and a stepwise 
procedure to assess whether age represents an in-
dependent prognostic factor. The results showed 
that age, tumor size, depth of invasion, lymph node 
metastasis, peritoneal metastasis, liver metastasis, 
lymphatic or blood vessel invasion and curability 
were independent prognostic factors (Table 2). 
 
 
Fig. 1. Survival curves in age-classified patients with 
gastric cancer. Five-year survival rates are 61.0%, 73.6% 
and 68.1% in young, middle-aged and elderly patients, 
respectively. The prognosis in the middle-aged patients is 
significantly better than that in either the young or elderly 
patients (P < 0.05). [  ], number of patients; (  ), %.
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Age and recurrence pattern 
Figure 2 shows the correlation between age and 
mode of recurrence. Peritoneal recurrence was more 
frequently observed in the young patients than in 
either the middle-aged or elderly patients (P < 0.05). 
Moreover, hematogenous recurrence was more fre-
quently observed in both the young (P < 0.01) and 
elderly patients (P < 0.001) than in the middle-aged 
patients. 
 
 
Discussion
 
We have previously demonstrated that gastric can-
cer in the elderly is characterized by high frequency 
of differentiated cancer, blood vessel invasion, he-
matogenous recurrence and poor prognosis (Saito 
et al., 2006). Therefore, age might have an impact 
on clinicopathologic characteristics, mode of recur-
rence and prognosis in patients with gastric cancer. 
 In the present study, the prognosis of gas-
tric cancer patients in either the young age or old 
age group was significantly worse than that in the 
middle-aged population. On the other hand, there 
are conflicting results with regard to the prognosis 
of gastric cancer in young patients (Tso et al., 1987; 
Okamoto et al., 1988; Kim et al., 2003). We have 
Table 2. Multivariate analysis of various clinicopathologic factors in patients with gastric carcinoma
 
 Variable Hazard 95% confidence P
   ratio    interval value
 
Tumor size [continuous variable] 1.042 1.022–1.062 < 0.0001
Age 
     Young (versus middle-aged) 1.577 1.079–2.304 0.019
     Elderly (versus middle-aged) 1.482 1.227–1.790 < 0.0001
Depth of invasion (T1–T4)*  2.066 1.812–2.356 < 0.0001
Lymph node metastasis (N0–N3)†  1.550 1.425–1.687 < 0.0001
Lymphatic vessel invasion (Ly0–Ly3)‡  1.207 1.108–1.314 < 0.0001
Blood vessel invasion (V0–V3)§ 1.095 1.012–1.184   0.024
Peritoneal metastasis (presence or absence)  1.388 1.237–1.557 < 0.0001
Liver metastasis (presence or absence)  1.449 1.270–1.652 < 0.0001
Curability 2.532 1.972–3.257 < 0.0001
 
* T1, tumor invasion of the lamina propria or submucosa; T2, invasion of the muscularis propria or the subserosa; T3, 
penetration of the serosa; T4, invasion of adjacent organs.
† N0, no regional lymph node metastasis; N1–N3, metastasis in group-1 to -3 lymph nodes.
‡ Ly0–Ly3, grade of lymphatic invasion. 
§ V0–V3, grade of blood vessel invasion.   
previously reported that prognosis of gastric can-
cer in elderly patients is poor (Saito et al., 2006). 
Most previous studies have classified patients into 2 
groups, either young or the rest, and have compared 
prognosis between the 2 groups. Therefore, the ad-
dition of elderly patients, whose prognosis was poor, 
to the middle-aged patients, whose prognosis was 
good, might lead to different results for prognosis. 
Fig. 2. The correlation between age and mode of recur-
rence. Peritoneal recurrence is more frequently observed 
in young patients than either middle-aged or elderly pa-
tients (P < 0.05). Moreover, hematogenous recurrence is 
more frequently observed in both young (P < 0.01) and 
elderly patients (P < 0.001) than middle-aged patients.
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In fact, in the present study, there were no signifi-
cant differences in the prognosis between patients 
aged ≤ 40 and those > 40 years (data not shown). 
Therefore, we recommend classifying patients into 
3 groups, the young, middle-aged and elderly like 
we did in the present study, when the correlation be-
tween age and prognosis is determined.
 As reported in previous papers (Bloss et al., 
1980; Mori et al., 1985; Sandler and Holland, 1987; 
Tso et al., 1987), our results also demonstrated that 
the male-to-female ratio showed a predominance of 
female patients in the young age group. Undifferen-
tiated carcinoma was also observed more frequently 
in the young age group. Moreover, the frequency 
of peritoneal metastasis was high in the young pa-
tients. With regard to mode of recurrence, peritone-
al recurrence was observed more frequently in the 
young than in either the middle-aged or elderly pa-
tients (P < 0.05). It has been reported that undiffer-
entiated gastric cancer preferentially metastasizes to 
the peritoneum (Moriguchi et al., 1991). Therefore, 
a high frequency of peritoneal recurrence might be 
correlated with a high frequency of undifferentiated 
gastric cancer in the young patients.
 The Adjuvant Chemotherapy Trial of TS-1 
for Gastric Cancer phase III trial has demonstrated 
that S-1 was effective as adjuvant chemotherapy for 
Japanese patients who had undergone curative D2 
gastrectomy for gastric cancer and were diagnosed 
with pathological stage-2 or -3 disease (Sakuramoto 
et al., 2007). Therefore, a curative D2 dissection 
and adjuvant chemotherapy with S-1 are now the 
standard therapy for these patients in Japan (Sano 
and Aiko, 2011). On the other hand, majority of pa-
tients included in the present study did not take S-1 
after operation as S-1 became commercially avail-
able since 1999. Therefore, S-1 may significantly 
improve the prognosis of the young patients since 
continuation of S-1 adjuvant chemotherapy is con-
sidered better than the elderly patients.
 In conclusion, gastric cancer in young patients 
has unique characteristics, namely, a female pre-
dominance, a high frequency of undifferentiated 
cancer and peritoneal metastasis and recurrence. On 
account of the extremely poor prognosis in young 
patients, intensive chemotherapy should be consid-
ered even after curative operation. 
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